309 related articles for article (PubMed ID: 33834417)
41. Epigenetics and depressive disorders: a review of current progress and future directions.
Januar V; Saffery R; Ryan J
Int J Epidemiol; 2015 Aug; 44(4):1364-87. PubMed ID: 25716985
[TBL] [Abstract][Full Text] [Related]
42. The State of Our Understanding of the Pathophysiology and Optimal Treatment of Depression: Glass Half Full or Half Empty?
Nemeroff CB
Am J Psychiatry; 2020 Aug; 177(8):671-685. PubMed ID: 32741287
[TBL] [Abstract][Full Text] [Related]
43. Towards precision medicine in generalized anxiety disorder: Review of genetics and pharmaco(epi)genetics.
Tomasi J; Lisoway AJ; Zai CC; Harripaul R; Müller DJ; Zai GCM; McCabe RE; Richter MA; Kennedy JL; Tiwari AK
J Psychiatr Res; 2019 Dec; 119():33-47. PubMed ID: 31563039
[TBL] [Abstract][Full Text] [Related]
44. The Role of Biomarkers in Psychiatry.
Lozupone M; La Montagna M; D'Urso F; Daniele A; Greco A; Seripa D; Logroscino G; Bellomo A; Panza F
Adv Exp Med Biol; 2019; 1118():135-162. PubMed ID: 30747421
[TBL] [Abstract][Full Text] [Related]
45. Epigenetic Aging in Major Depressive Disorder.
Han LKM; Aghajani M; Clark SL; Chan RF; Hattab MW; Shabalin AA; Zhao M; Kumar G; Xie LY; Jansen R; Milaneschi Y; Dean B; Aberg KA; van den Oord EJCG; Penninx BWJH
Am J Psychiatry; 2018 Aug; 175(8):774-782. PubMed ID: 29656664
[TBL] [Abstract][Full Text] [Related]
46. Precision and personalized assessment, diagnosis and treatment in psychiatry.
Fountoulakis KN; Stahl SM
CNS Spectr; 2021 Aug; 26(4):326-332. PubMed ID: 32228728
[TBL] [Abstract][Full Text] [Related]
47. Die "Präzisionspsychiatrie" muss Teil der "personalisierten Psychiatrie" werden.
Giordano GM; Pezzella P; Perrottelli A; Galderisi S
Fortschr Neurol Psychiatr; 2020 Nov; 88(12):767-772. PubMed ID: 32869236
[TBL] [Abstract][Full Text] [Related]
48. DNA methylation and clinical response to antidepressant medication in major depressive disorder: A review and recommendations.
Lisoway AJ; Zai CC; Tiwari AK; Kennedy JL
Neurosci Lett; 2018 Mar; 669():14-23. PubMed ID: 28063933
[TBL] [Abstract][Full Text] [Related]
49. Machine Learning in Neural Networks.
Lin E; Tsai SJ
Adv Exp Med Biol; 2019; 1192():127-137. PubMed ID: 31705493
[TBL] [Abstract][Full Text] [Related]
50. How to determine whether conceptual endophenotypes can improve clinical outcomes in patients suffering from major depression: An exploratory approach.
Bergemann N; Bruhn K; Loscheider K; Vogt D; Böhnke JR; Gerhards F
Psychoneuroendocrinology; 2019 Jul; 105():195-204. PubMed ID: 30954330
[TBL] [Abstract][Full Text] [Related]
51. Blood biomarkers and treatment response in major depression.
Mora C; Zonca V; Riva MA; Cattaneo A
Expert Rev Mol Diagn; 2018 Jun; 18(6):513-529. PubMed ID: 29701114
[TBL] [Abstract][Full Text] [Related]
52. Precision Psychiatry and Dual Disorders.
Szerman N; Peris L
J Dual Diagn; 2018; 14(4):237-246. PubMed ID: 30638153
[TBL] [Abstract][Full Text] [Related]
53. Precision/Personalized Medicine in Allergic Diseases and Asthma.
Kucuksezer UC; Ozdemir C; Akdis M; Akdis CA
Arch Immunol Ther Exp (Warsz); 2018 Dec; 66(6):431-442. PubMed ID: 30251122
[TBL] [Abstract][Full Text] [Related]
54. Clinical and biological predictors of response to electroconvulsive therapy (ECT): a review.
Pinna M; Manchia M; Oppo R; Scano F; Pillai G; Loche AP; Salis P; Minnai GP
Neurosci Lett; 2018 Mar; 669():32-42. PubMed ID: 27793702
[TBL] [Abstract][Full Text] [Related]
55. Discovering imaging endophenotypes for major depression.
Hasler G; Northoff G
Mol Psychiatry; 2011 Jun; 16(6):604-19. PubMed ID: 21602829
[TBL] [Abstract][Full Text] [Related]
56. Establishing moderators and biosignatures of antidepressant response in clinical care (EMBARC): Rationale and design.
Trivedi MH; McGrath PJ; Fava M; Parsey RV; Kurian BT; Phillips ML; Oquendo MA; Bruder G; Pizzagalli D; Toups M; Cooper C; Adams P; Weyandt S; Morris DW; Grannemann BD; Ogden RT; Buckner R; McInnis M; Kraemer HC; Petkova E; Carmody TJ; Weissman MM
J Psychiatr Res; 2016 Jul; 78():11-23. PubMed ID: 27038550
[TBL] [Abstract][Full Text] [Related]
57. Can epigenetic biomarkers lead us to precision medicine in predicting treatment response and remission for patients being considered for ECT?
Feng T; Youssef NA
Psychiatry Res; 2020 Feb; 284():112659. PubMed ID: 31703983
[TBL] [Abstract][Full Text] [Related]
58. Epigenetic Modifications of Major Depressive Disorder.
Saavedra K; Molina-Márquez AM; Saavedra N; Zambrano T; Salazar LA
Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27527165
[TBL] [Abstract][Full Text] [Related]
59. Biomarkers in Psychiatry: Concept, Definition, Types and Relevance to the Clinical Reality.
García-Gutiérrez MS; Navarrete F; Sala F; Gasparyan A; Austrich-Olivares A; Manzanares J
Front Psychiatry; 2020; 11():432. PubMed ID: 32499729
[TBL] [Abstract][Full Text] [Related]
60. Breakthroughs and challenges for generating brain network-based biomarkers of treatment response in depression.
Prompiengchai S; Dunlop K
Neuropsychopharmacology; 2024 Jul; ():. PubMed ID: 38951585
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
